Drug Profile
Curcumin - Seer Pharmaceuticals
Latest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator Seer Pharmaceuticals
- Developer Cystic Fibrosis Foundation Therapeutics; Seer Pharmaceuticals
- Class Anti-ischaemics; Antihistamines; Antivirals; Catechols; Chemopreventatives; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cystic fibrosis